WEAK BUY
In a rally along with the other tech stocks. Expecting them to do well in their upcoming report. The real key is where they are going to guide. Concerned about the longer term and where the video control goes.
BUY
Likes this stock. Expensive, but they are continuing to ramp up. Developing a consumer model. Can see them going from 2 million units to 4/5/10 million 3/5 years. Good growth path.
BUY
Has delivered on all their prduction targets. Expect them to continue to grow. Good properties in Saskatchewan that could add significant barrels. Long reserve life. Trades relatively cheap to the group.
WEAK BUY
Stock has done very well and still has some potential based on their endless spinoffs from CSI. Questions where their next leg of growth will come from.
DON'T BUY
Priced for perfection. Fundamentally it's a high return on capital business but is priced very expensive. High potential for disappointment and for overshooting. Volatile. Treat as a trading stock.
DON'T BUY
Priced for perfection. Fundamentally it's a high return on capital business but is priced very expensive. High potential for disappointment and for overshooting. Volatile. Treat as a trading stock.
DON'T BUY
Priced for perfection. Fundamentally it's a high return on capital business but is priced very expensive. High potential for disappointment and for overshooting. Volatile. Treat as a trading stock.
BUY
Best to own a basket when owing smaller bio techs. Gigh risk/high return. Their diabetes drug, if it flows through, has a huge market potential. News flow has been fairly good. Still early stage. Good management.
BUY
Was considering, but the recent runup caused him to look elsewhere. Prefers Ensign which trades at a significant valuation discount to this one. Expects drilling activity will be high.
BUY
Was considering Precision Drilling, but the recent runup caused him to look elsewhere. Chose Ensign which trades at a significant valuation discount to Precision. Expects drilling activity will be high.
BUY ON WEAKNESS
Executed on their plans extremely well. Trades in the 15 P/E range. Should continue to do well.
WEAK BUY
3.5% dividend. For dividends, you are better off with a Canadian bank which eliminates withholding tax. Would prefer some Cdn banks because of their better opportunity to grow.
DON'T BUY
Looks expensive. Their struggles with their US operations are not reflected in the price. Would consider if it was trading at a discount to its peers.
DON'T BUY
Valuation seems attractive but could be better.
PAST TOP PICK
(A Top Pick May 28/04. Down 8%.) Still likes. Downside is limited. Dividend is safe for the next couple of years.